Undertake New Challenges in the Field

The Therapeutics Initiative will launch small working groups to tackle challenging programs in disease and/or technology in science today. The goal of the Disease & Technology Groups at HMS is to catalyze translational research ideation, followed by action, and address hard problems and unmet medical needs. The program will help faculty convene working groups and leverage time and resources by providing ideation, fundraising, and management support through a dedicated fellows program, the Therapeutics Innovation Fellows.

Connect with the Community

 Drug discovery and diagnostics projects generally require a team with expertise in multiple areas. Our goal is to connect different people from various backgrounds and expertise to facilitate the exchange of ideas and collaboration.

Work with a Therapeutics Innovation Fellow

Therapeutics Innovation Fellows will organize collaborative research programs across small faculty groups linked by common interest in a disease or technology. The Therapeutics Innovation Fellows will organizing, manage, and help raise funds for these collaborative programs.

Graphic showing the possible configurations of a disease and technology group, including HMS quad faculty, industry scientists, physicians, patient advocates, disease foundation leaders, staff, students, and post docs

Active Projects

  • Coronavirus Disease 2019 (COVID-19)

    From the Centers for Disease Control and Prevention:

    COVID-19 is a respiratory disease caused by SARS-CoV-2, a new coronavirus discovered in 2019. The virus is thought to spread mainly from person to person through respiratory droplets produced when an infected person coughs, sneezes, or talks. Some people who are infected may not have symptoms. For people who have symptoms, illness can range from mild to severe. Adults 65 years and older and people of any age with underlying medical conditions are at higher risk for severe illness.

  • Lyme Disease

    From the Centers for Disease Control and Prevention:

    Lyme disease is the most common vector-borne disease in the United States. Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. Lyme disease is diagnosed based on symptoms, physical findings (e.g., rash), and the possibility of exposure to infected ticks.  Laboratory testing is helpful if used correctly and performed with validated methods. Most cases of Lyme disease can be treated successfully with a few weeks of antibiotics. Steps to prevent Lyme disease include using insect repellent, removing ticks promptly, applying pesticides, and reducing tick habitat. The ticks that transmit Lyme disease can occasionally transmit other tickborne diseases as well.